Encompass Health Corp (NYSE: EHC) kicked off on Friday, up 0.35% from the previous trading day, before settling in for the closing price of $94.41. Over the past 52 weeks, EHC has traded in a range of $69.72-$104.55.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 1.51%. While this was happening, its average annual earnings per share was recorded 18.08%. With a float of $99.26 million, this company’s outstanding shares have now reached $100.80 million.
The extent of productivity of a business whose workforce counts for 37761 workers is very important to gauge. In terms of profitability, gross margin is 22.41%, operating margin of 15.76%, and the pretax margin is 13.67%.
Encompass Health Corp (EHC) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Medical Care Facilities Industry. The insider ownership of Encompass Health Corp is 1.48%, while institutional ownership is 96.31%. The most recent insider transaction that took place on Aug 13 ’24, was worth 1,058,474. In this transaction EVP & Chief Financial Officer of this company sold 12,260 shares at a rate of $86.34, taking the stock ownership to the 136,227 shares. Before that another transaction happened on Aug 13 ’24, when Company’s Officer proposed sale 12,260 for $86.34, making the entire transaction worth $1,058,520.
Encompass Health Corp (EHC) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.2 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 18.08% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 17.63% during the next five years compared to 3.48% growth over the previous five years of trading.
Encompass Health Corp (NYSE: EHC) Trading Performance Indicators
Take a look at Encompass Health Corp’s (EHC) current performance indicators. Last quarter, stock had a quick ratio of 1.04. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.83. Likewise, its price to free cash flow for the trailing twelve months is 36.91.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 4.14, a number that is poised to hit 1.02 in the next quarter and is forecasted to reach 4.77 in one year’s time.
Technical Analysis of Encompass Health Corp (EHC)
The latest stats from [Encompass Health Corp, EHC] show that its last 5-days average volume of 0.43 million was inferior to 0.55 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 91.85%. Additionally, its Average True Range was 1.76.
During the past 100 days, Encompass Health Corp’s (EHC) raw stochastic average was set at 41.26%, which indicates a significant decrease from 89.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 15.34% in the past 14 days, which was lower than the 19.82% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $97.97, while its 200-day Moving Average is $90.87. Now, the first resistance to watch is $95.41. This is followed by the second major resistance level at $96.07. The third major resistance level sits at $96.58. If the price goes on to break the first support level at $94.24, it is likely to go to the next support level at $93.73. Assuming the price breaks the second support level, the third support level stands at $93.07.
Encompass Health Corp (NYSE: EHC) Key Stats
The company with the Market Capitalisation of 9.55 billion has total of 100,750K Shares Outstanding. Its annual sales at the moment are 4,801 M in contrast with the sum of 352,000 K annual income. Company’s last quarter sales were recorded 1,351 M and last quarter income was 108,200 K.
